Speaker illustration

Doctor Anna Planavila

University of Barcelona, Barcelona (Spain)

Member of:

European Society of Cardiology

Group leader of the Molecular Cardiology Laboratory (University of Barcelona, IBUB). PhD thesis in 2005. Excellent Cum Laude. Extraordinary Doctorate Award 2006. At 2005 she started a post-doctoral stay at the Maastricht Cardiovascular Research Institute (CARIM),(The Nehterlands); competitive postdoctoral grant MEC / Fullbright (Ministry of Education and Science of Spain). After that, she obtained a competitive postdoctoral contract Sara Borrell, Carlos III Health Institute, MCINN for research at Faculty of Biology. University of Barcelona (2008). Ramon y Cajal researcher (2016). Associate Professor (2021) Line of research: "Identification of new cardiokines, proteins secreted by the heart with autocrine, paracrine and/or endocrine properties that may be important both for the treatment of heart disease and its possible use as biomarkers for the diagnosis of heart diseases"

Advances in the "heart-fat interface" in cardiovascular disease: opportunities for personalised strategies

Event: Frontiers in CardioVascular Biomedicine 2026

Topic: Cardiac Diseases

Session type: Advances in Science

Thumbnail

Genetic and epigenetic regulation of cardiovascular disease: mechanisms and therapeutic opportunities

Event: ESC Congress 2025

Topic: Genetics, Epigenetics, ncRNA

Session type: Moderated ePosters

Thumbnail